This guide assists in making TB control policy decisions and plans for successfully introducing fixed-dose combination drugs (FDCs). This guide is intended for national TB program managers, DOTS strategy implementers, drug procurement officers/personnel, DOT providers, and drug regulatory authorities.
Audiences:
Health Professionals
Policy Makers
Focus Area:
TB
Subjects:
Program Management
TB Treatment
Treatment Guidelines Materials
Treatment- Adverse Reactions
Treatment- Directly Observed Therapy (DOT)
Treatment- Medication Information
Publication Date:
2002
Format:
Guideline
Last Updated Date:
Publication ID:
32401